Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
460 hedge funds and large institutions have $10.5B invested in Abiomed Inc in 2020 Q2 according to their latest regulatory filings, with 90 funds opening new positions, 140 increasing their positions, 166 reducing their positions, and 40 closing their positions.
125% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 40
68% more capital invested
Capital invested by funds: $6.25B → $10.5B (+$4.23B)
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
12% more funds holding
Funds holding: 412 → 460 (+48)
13% less call options, than puts
Call options by funds: $154M | Put options by funds: $177M
16% less repeat investments, than reductions
Existing positions increased: 140 | Existing positions reduced: 166
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$49.8M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$48M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$44.5M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$41.2M |
| 5 |
Renaissance Technologies
New York
|
+$40.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$115M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$79.2M |
| 3 |
Primecap Management
Pasadena,
California
|
-$56.5M |
| 4 |
DM
Deerfield Management
New York
|
-$54.6M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$31.4M |
ABMD Hedge Fund Activity: Q2 2020 in Review
460 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2020, worth a combined $10.5B — up 68% from $6.25B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new ABMD positions and 40 closed out — a net gain of 50 holders — while 140 added to existing stakes and 166 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $49.8M. The largest seller was Wellington Management Group, cutting an estimated $115M.
- 460 institutional investors held Abiomed Inc (ABMD) as of Q2 2020, up from 412 in Q1 2020.
- Funds reported $10.5B of Abiomed Inc stock for Q2 2020, up 68% quarter-over-quarter.
- 90 funds opened new Abiomed Inc positions in Q2 2020 and 40 closed out, a net change of +50 holders.
- The largest Abiomed Inc buyer in Q2 2020 was JP Morgan Chase, an estimated $49.8M added.
- The largest Abiomed Inc seller in Q2 2020 was Wellington Management Group, an estimated $115M sold.
Based on aggregated 13F filings for Q2 2020.